Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

FTH holding history

Faeth Therapeutics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FTH overviewAll 13F holders of FTHFull Q2 2026 holdings

Shares (Q2 2026)
14,616
Value
$365.4K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of FTH by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,616$365.4K<0.1%+5,115+53.8%AddedHolders
Q1 20269,501$299.5K<0.1%+9,501NewHolders
Q2 20250$00.0%−7,535−100.0%Sold outConverted for a 1-for-20 splitHolders
Q1 2025150,709$59.4K<0.1%+1,822+1.2%AddedHolders
Q4 2024148,887$73.0K<0.1%−14,252−8.7%ReducedHolders
Q3 2024163,139$97.6K<0.1%00.0%UnchangedHolders
Q2 2024163,139$101.2K<0.1%+26,821+19.7%AddedHolders
Q1 2024136,318$143.2K<0.1%00.0%UnchangedHolders
Q4 2023136,318$94.3K<0.1%00.0%UnchangedHolders
Q3 2023136,318$102.3K<0.1%+38,312+39.1%AddedHolders
Q2 202398,006$111.7K<0.1%00.0%UnchangedHolders
Q1 202398,006$147.0K<0.1%00.0%UnchangedHolders
Q4 202298,006$146.0K<0.1%+6,111+6.6%AddedHolders
Q3 202291,895$142.0K<0.1%00.0%UnchangedHolders
Q2 202291,895$208.0K<0.1%−163,933−64.1%ReducedHolders
Q1 2022255,828$590.0K<0.1%−690−0.3%ReducedHolders
Q4 2021256,518$1.49M<0.1%−17,460−6.4%ReducedHolders
Q3 2021273,978$2.88M<0.1%+132,169+93.2%AddedHolders
Q2 2021141,809$1.38M<0.1%+24,403+20.8%AddedHolders
Q1 2021117,406$1.71M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.